Skip to content
The Nexus
DossierENTITY

Jiangsu Hengrui Pharmaceuticals

Coverage of Jiangsu Hengrui Pharmaceuticals in the Nexus archive.

Earliest in view: May 12 · 06:38 UTCMost recent: May 12 · 06:38 UTC
Co-mentioned in this coverage
Bristol-Myersorganization1
Recent coverage
  • BUSINESSMay 12 · 06:38 UTCBLOOMBERG
    Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui

    Bristol-Myers has signed a licensing deal worth up to $15 billion with Jiangsu Hengrui Pharmaceuticals. The deal is for branding and licensing of certain products. This partnership is expected to expand the reach of both companies.

Jiangsu Hengrui Pharmaceuticals · Dossier · The Nexus